Asianet News English

COVID-19: Pfizer tells Centre its vaccine suitable for 12 years and above; 50 million doses to be to India

 US pharmaceutical giant Pfizer has said that it is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions. However, the US drugmaker has asked for relaxations in some clauses, including indemnification for its shots, sources informed.
 

COVID-19: Pfizer tells Centre its vaccine suitable for 12 years and above; 50 million doses to be to India-dnm
Author
New Delhi, First Published May 27, 2021, 1:00 PM IST
  • Facebook
  • Twitter
  • Whatsapp

New Delhi: American pharmaceutical giant Pfizer has informed the Central government that its Covid-19 vaccine is suitable for all aged 12 and above and can be stored at 2-8 degrees for over a month.

They (Pfizer and the Indian government) also discussed the indemnity protection against liabilities and asked for relaxations in some clauses before the company brings its Covid-19 vaccines to India, the sources added.

US pharmaceutical giant Pfizer has said that it is likely to supply 50 million Covid-19 vaccines to India in 2021, albeit with a few conditions. However, the US drugmaker has asked for relaxations in some clauses, including indemnification for its shots, sources informed.

Meanwhile, Moderna, another pharmaceutical giant in the US, sources said, is expecting to start manufacturing its Covid-19 vaccines in India following an analysis with Cipla, a pharmaceutical company based in Mumbai, among other Indian firms.

Earlier, both drugmakers had allegedly refused to send vaccines directly to the state governments of Delhi and Punjab, claiming that they will only deal with the Central government.

"We have spoken to Pfizer and Moderna for vaccines, and both the companies have refused to sell vaccines directly to us. They have said that they will deal with the Government of India alone," Delhi Chief Minister Arvind Kejriwal had said on Monday.

India is moving towards vaccine sufficiency as inoculations with the Russian vaccine Sputnik V began in the country earlier this month. Sources said that India and Russia are planning to manufacture around 35-40 million doses every month that will start from August or September.

Before the transfer of technology in August for local production, Russia will send close to 18 million Sputnik V doses to India - 3 million in May, 5 million in June and 10 million in July said sources.

NOTE: Asianet News humbly requests everyone to wear masks, sanitize, maintain social distancing and get vaccinated as soon as eligible. Together we can and will break the chain #ANCares #IndiaFightsCorona 

Follow Us:
Download App:
  • android
  • ios